Low ERCC1 expression in tumor tissue has been correlated with better survival in non-small-cell lung cancer (NSCLC) [18,19,20] and in SCLC patients treated with platinum-based chemotherapy [21,22]. The gene discussed is ERCC1; the disease is non-small cell lung carcinoma.